Live Breaking News & Updates on Core Faculty Member
Stay updated with breaking news from Core faculty member. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FIND Cell is a new tool that digitizes cell culture to enable reproducible biomedical science New cloud based software platform reduces research costs and improves speed and reliability News provided by Share this article Share this article NEW YORK, May 19, 2021 /PRNewswire/ Lack of reproducibility is a critical problem in biomedical science, wasting both time and billions of dollars every year. The Correspondence Tracking cell lineages improves research reproducibility , published today in Nature Biotechnology, lays the scientific foundation for a brand-new software platform called FIND Cell; a unique tool that aims to improve reproducibility of cell-based science. FIND Cell (available at https://findgen.bio/) integrates daily cell line tracking with genetic verification. It enables scientists to digitize, organise, verify, and find their cell culture related information – which is critical for biomedical research. ....
Novel integrative genetic screening platform offers insights into role of DNA accessibility in cancer In a new resource for the scientific community, published today in Nature Biotechnology, researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center (NYGC) and New York University (NYU) developed CRISPR-sciATAC, a novel integrative genetic screening platform that jointly captures CRISPR gene perturbations and single-cell chromatin accessibility genome-wide. With this technology, they profile changes in genome organization and create a large-scale atlas of how loss of individual chromatin-altering enzymes impacts the human genome. The new method harnesses the programmability of the gene editing system CRISPR to knock-out nearly all chromatin-related genes in parallel, offering researchers deeper insights into the role of DNA accessibility in cancer and in rare diseases involving chromatin. ....
E-Mail IMAGE: CRISPR-sciATAC is a novel integrative genetic screening platform that jointly captures CRISPR gene perturbations and single-cell chromatin accessibility genome-wide. The new method harnesses the programmability of the gene editing system. view more Credit: Sanjana Lab of New York Genome Center and NYU NEW YORK, NY (April 29, 2021) - In a new resource for the scientific community, published today in Nature Biotechnology, researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center (NYGC) and New York University (NYU) developed CRISPR-sciATAC, a novel integrative genetic screening platform that jointly captures CRISPR gene perturbations and single-cell chromatin accessibility genome-wide. With this technology, they profile changes in genome organization and create a large-scale atlas of how loss of individual chromatin-altering enzymes impacts the human genome. The new method harnesses the programmability of the gene ed ....
Meet the Team: Patricia Cortes, Human Capital Initiative | Global Development Policy Center bu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bu.edu Daily Mail and Mail on Sunday newspapers.
D614G Mutation Makes SARS-CoV-2 Eight Times More Infectious technologynetworks.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from technologynetworks.com Daily Mail and Mail on Sunday newspapers.